A pulmonologist describes how using an esophageal balloon can provide a more precise diagnosis and hemodynamic classification of pulmonary hypertension.
Case Study: Invasive Cardiopulmonary Exercise Testing Helps Uncover True Cause of Dyspnea
Invasive cardiopulmonary exercise testing helps uncover the true cause of dyspnea in a 51-year-old man.
Treprostinil: First Drug Approved for Patients with Pulmonary Hypertension and Interstitial Lung Disease
Compared with placebo, inhaled treprostinil was associated with lower risk of clinical worsening and fewer exacerbations of underlying lung disease during a 16-week treatment period.
Multidisciplinary Clinic Facilitates Optimal Treatment for Patients With Congenital Heart Disease and Pulmonary Hypertension
Cleveland Clinic pulmonary hypertension and congenital heart disease specialists sought to address an unmet clinical need by combining their expertise.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Pulmonary Artery Catheterization for Evaluation of Pulmonary Hypertension
While pulmonary artery catheterization is the gold standard to diagnose pulmonary hypertension, it has limitations. A Cleveland Clinic pulmonologist discusses the strategies his lab is using to better understand cardiopulmonary hemodynamics and more precisely characterize the type of pulmonary hypertension.
Exploring Novel Treatment for CTD-Associated Pulmonary Hypertension
Approved vasodilation therapies generally don’t improve function in patients with pulmonary hypertension associated with connective tissue disease. The Catalyst study explores the use of bardoxolone in these patients.
Evaluating WHO Group 5 Pulmonary Hypertension and Prognostic Risk Stratification
Since multiple conditions can mimic components of PH, the clinician should think about the patient’s total clinical condition before diagnosing and categorizing it. Proper evaluation and etiologic definition are crucial to providing the appropriate therapy and prognosis.
Evaluating Suspected Pulmonary Hypertension Due to Left Heart Disease
Since multiple conditions can mimic components of PAH, the clinician should think about the patient’s total clinical condition before diagnosing and categorizing it. Proper evaluation and etiologic definition are crucial to providing the appropriate therapy.
Kidney Disease and Pulmonary Hypertension: A Deadly Duo
Cleveland Clinic research finds that chronic kidney disease is widely prevalent in patients with pulmonary hypertension, and that lower levels of kidney function are associated with an increased risk of death.
Exploring Pulmonary Hypertension in Inflammatory Myopathy
A Cleveland Clinic study to determine the prevalence of pulmonary hypertension in patients with inflammatory myopathies (IM) seems to indicate that routine screening of IM patients may be worthwhile.